Home › NDC Lookup › RxCUI directory › RxCUI 2639721

Nalmefene 27 MG/ML Nasal Spray — RxCUI 2639721

RxNorm drug concept · Semantic clinical drug
RxCUI 2639721 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2639721
Official nameNalmefene 27 MG/ML Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnalmefene 2.7 MG per 0.1 ML Nasal Spray; nalmefene 2.7 MG in 0.1 ML Nasal Spray; nalmefene 2.7 MG (equivalent to nalmefene HCl 3 MG) per 0.1 ML Nasal Spray
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)1,284 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Nalmefene 27 MG/ML Nasal Spray Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nalmefene 27 MG/ML Nasal Spray RxCUI 2639721

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nalmefene 31479
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Opvee 2639722
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nalmefene Nasal Spray 2639720
    • Nalmefene Inhalant Product 2639718
    • Nalmefene Nasal Product 2639719
    • Nalmefene Nasal Spray [Opvee] 2639726
    • Opvee Inhalant Product 2639724
    • Opvee Nasal Product 2639725
    • Nasal Spray 126542
    • Inhalant Product 1151123
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nalmefene 27 MG/ML SCDC · 2639717
  • Nalmefene Nasal Spray SCDF · 2639720
  • Nalmefene Inhalant Product SCDG · 2639718
  • Nalmefene Nasal Product SCDG · 2639719

Brand-Name Concepts

  • Nalmefene 27 MG/ML Nasal Spray [Opvee] SBD · 2639727
  • Nalmefene 27 MG/ML [Opvee] SBDC · 2639723
  • Nalmefene Nasal Spray [Opvee] SBDF · 2639726
  • Opvee Inhalant Product SBDG · 2639724
  • Opvee Nasal Product SBDG · 2639725
  • Opvee BN · 2639722

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2639721 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
12496-0003-02 2 BLISTER PACK in 1 CARTON (12496-0003-2) / 1 VIAL, SINGLE-... OPVEE Indivior Inc. 2023-10-02
Observed labelers: Indivior Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$46.7887
Range $46.7887–$46.7887 · middle 50% $46.7887–$46.7887 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.